NFKB1 and Miyoshi myopathy: We demonstrated that CK2 inhibitors cooperate with bortezomib in causing MM and MCL cell apoptosis by down modulating the signalling cascades of NF-κB and STAT3 and by potentiating the proteotoxic effects due to proteasome blockage.